Navigation Links
Plant hormone auxin triggers a genetic switch

This release is available in German.

During the development of organisms, a particular event repeatedly occurs: a signal appears temporarily, but the processes it triggers must be maintained for example, when the fate of cells in the embryo is established. The plant hormone auxin plays an important role as a signalling molecule during embryo development of the thale cress (Arabidopsis thaliana), a model plant widely used in genetic studies. Researchers from the Max Planck Institute for Developmental Biology and the University of Tbingen were already familiar with important components, through which auxin exerts its influence, and some of their interactions. They have now combined several of these components in a regulatory network such that an increasing concentration of auxin can "switch on" genes for the embryo's normal development. Once a certain point has been reached, the genes do not halt their increased activity, or only do so gradually, even if the auxin concentration declines. Similar switching mechanisms are also known from the animal kingdom.

In the normal course of events, a plant embryo becomes a seedling and the seedling grows into a plant with all of its organs: roots, stem, leaves and flowers. The foundations for this development are laid during early embryonic development. The plant hormone auxin is an important signal transmitter during this phase of development. It was already known that it promotes, for example, the breakdown of an inhibitor that can prevent certain factors from activating their target genes. In an early phase of embryo development, the auxin concentration rises in the cells located at the top of the embryo, from which the above-ground parts of the plant will later form. Shortly after that, auxin is transported into the lower cells. So complicated, so good. However, this does not fully explain the exact role of auxin in pattern formation in the embryo.

In their study on the effect of auxin, Steffen Lau, Ive De Smet, Martina Kolb and Gerd Jrgens from the Department of Cell Biology and Hans Meinhardt, all from the Max Planck Institute for Developmental Biology in Tbingen, and some also affiliated with the University of Tbingen, initially focused on a simplified system. Instead of carrying out their experiments with thale cress (Arabidopsis thaliana) embryos, they worked with thale cress protoplasts: living cells without a cell wall that offer a less complex environment. Test conditions using protoplasts can be varied rather conveniently, and it is relatively easy to measure gene activity in these cells. Using this system, the scientists tested the effects of a gene-activating factor called MONOPTEROS and that of its inhibitor BODENLOS. This and subsequent experiments showed that MONOPTEROS promotes both its own production and that of its inhibitor BODENLOS. They form a system comprising two linked feedback loops. The system is controlled by auxin, which promotes the breakdown of the inhibitor.

Based on these results, the scientists also carried out computer simulations in which they reconstructed the regulatory network. "Everything points to the fact that auxin triggers a switch in the system," says Steffen Lau. And this is how it works: when the concentration of auxin increases, breakdown of the inhibitor BODENLOS also increases. As a result, MONOPTEROS is less strongly blocked. And once a certain auxin concentration is reached, the MONOPTEROS-BODENLOS system is boosted to a higher level of activity. "As long as the auxin concentration does not fall below a certain level, the activated system does not fall back to the initial level, even if most of the auxin is transported away," explains the scientist.

This regulatory mechanism in the embryonic development of plants had not previously been described, and displays similarities to a signalling pathway in embryonic stem cells in mammals, for example. "Whether this type of regulation occurs in other developmental processes in thale cress remains to be investigated," says Steffen Lau.


Contact: Gerd Juergens

Related biology news :

1. Ancestors of land plants revealed
2. The Last Great Plant Hunt: The story of Kews Millennium Seed Bank
3. Studies of marine animals aim to help prevent rejection of transplanted organs
4. Improvements in embryonic preimplantation genetic screening techniques
5. Circadian rhythms spark plants ability to survive freezing weather
6. Combating plant diseases is key for sustainable crops
7. Shootingstars provide clues to likely response of plants to global warming
8. Periodontal stem cell transplantation shows promise
9. New genetic study helps to solve Darwins mystery about the ancient evolution of flowering plants
10. Are invasive plants a threat to native biodiversity? It depends on the spatial scale
11. If plants generate magnetic fields, theyre not sayin
Post Your Comments:
Related Image:
Plant hormone auxin triggers a genetic switch
(Date:10/7/2015)... -- --> --> According ... third quarter 2015 amounted to around 960 MSEK. This exceeds ... was communicated 20 August 2015. --> ... a continued growing demand for the company,s products, the revenues ... than during the third quarter. The revenue guidance for 2015 ...
(Date:10/6/2015)... 2015  Maverix Biomics, Inc., a leading genomic ... software portfolio with the debut of its RNA-Seq ... in eukaryotes. The software is integrated into the ... analysis solution that leverages proven open-source algorithms and ... efforts. Garry Nolan,s laboratory at ...
(Date:10/1/2015)... , Oct. 1, 2015  Biometrics includes diverse ... human body characteristics, such as fingerprints, eye retinas, ... Adoption of biometrics technology has been constantly increasing ... last five years. In addition to the most ... fingerprint recognition, other means of biometric authentication are ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... October 13, 2015 ARRY ), ... (NASDAQ: JUNO ), and Progenix Pharmaceuticals, Inc. (NASDAQ: ... Life Sciences Corp. (OTCQX: AVXLD), Juno Therapeutics, Inc. (NASDAQ: ... PGNX ) --> Cooperative research and development ... can potentially lead to advancements in the treatment of ...
(Date:10/13/2015)... JACKSONVILLE, Florida , October 13, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, will be a featured presenting company ... at the Wyndham Grand Hotel in ... --> TapImmune, Inc. (TPIV), a clinical-stage immunotherapy ...
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr and Ed Donaldson ... clinical data solutions business. , Jeff Parr has spent the past decade providing quality ... Dennison, Thermo Fisher, and Ab Sciex to name a few. He is based ...
(Date:10/13/2015)... the United States , Canada ... 14% of all new cases of kidney cancer.   --> ... and Europe .  PRCC represents about 14% ... Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison ... ("AstraZeneca") have completed enrolment in a global Phase II study of ...
Breaking Biology Technology: